These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7931671)

  • 61. [Experimental studies for immunoscintigraphy of adenocarcinoma of the prostate with 125I-labeled monoclonal antibody to gamma-seminoprotein].
    Fujino A; Suyama K; Shidara T; Ao T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):271-80. PubMed ID: 8121109
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
    Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
    Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM-2 labeled with 99mTc and radioiodine.
    Brümmendorf TH; Kaul S; Schuhmacher J; Baum RP; Matys R; Klivényi G; Adams S; Bastert G
    Cancer Res; 1994 Aug; 54(15):4162-8. PubMed ID: 8033148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma.
    Otsuji E; Matsumura H; Okamoto K; Toma A; Kuriu Y; Ichikawa D; Hagiwara A; Yamagishi H
    J Surg Oncol; 2003 Nov; 84(3):160-5. PubMed ID: 14598360
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody.
    Arano Y; Inoue T; Mukai T; Wakisaka K; Sakahara H; Konishi J; Yokoyama A
    J Nucl Med; 1994 Feb; 35(2):326-33. PubMed ID: 8295006
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Application of biotin-avidin system in targeted magnetic resonance imaging].
    Liu X; Xu YK; Ye J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Scintigraphy and biodistribution of monoclonal adrenocortical antibody in mice grafted with human adrenocortical carcinoma.
    Ohrvall U; Backlin K; Juhlin C; Westlin JE; Arnberg H; Bjerneroth G; Nilsson S; Akerström G; Rastad J
    Surgery; 1995 Nov; 118(5):893-900. PubMed ID: 7482278
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preliminary radioimmunoimaging and biodistribution of ¹³¹iodine-labeled single-chain antibody fragment against progastrin-releasing peptide(₃₁₋₉₈) in small cell lung cancer xenografts.
    Hong Z; Shi Y; Liu Z; Zhou X; Yang Y; Tang J
    Chin Med J (Engl); 2014; 127(11):2007-11. PubMed ID: 24890142
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo distribution of avidin-conjugated MX35 and (211)At-labeled, biotinylated poly-L-lysine for pretargeted intraperitoneal α-radioimmunotherapy.
    Frost SH; Bäck T; Chouin N; Jensen H; Hultborn R; Jacobsson L; Lindegren S
    Cancer Biother Radiopharm; 2011 Dec; 26(6):727-36. PubMed ID: 22087606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Technetium-99m-antiepidermal growth factor-receptor antibody in patients with tumors of epithelial origin: part II. Pharmacokinetics and clearances.
    Iznaga-Escobar N; Torres Arocha LA; Morales Morales A; Ramos Suzarte M; Rodríguez Mesa N; Pérez Rodríguez R
    J Nucl Med; 1998 Nov; 39(11):1918-27. PubMed ID: 9829584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Localization of radiolabeled monoclonal antibody in a human soft tissue sarcoma xenograft.
    Brown JM; Greager JA; Pavel DG; Gupta TK
    J Natl Cancer Inst; 1985 Oct; 75(4):637-44. PubMed ID: 3862896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
    Colcher D; Keenan AM; Larson SM; Schlom J
    Cancer Res; 1984 Dec; 44(12 Pt 1):5744-51. PubMed ID: 6498836
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
    Postema EJ; Frielink C; Oyen WJ; Raemaekers JM; Goldenberg DM; Corstens FH; Boerman OC
    Cancer Biother Radiopharm; 2003 Aug; 18(4):525-33. PubMed ID: 14503946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphoma.
    Buchsbaum DJ; Sinkule JA; Stites MS; Fodor PA; Hanna DE; Ford SM; Warber-Matich SL; Juni JE; Foon KA
    Cancer Res; 1988 May; 48(9):2475-82. PubMed ID: 3258544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pretargeted radioimmunoimaging with a biotinylated D-D
    Hong Z; Deng S; Shi Y; Xie Y; You J; Wang W; Huang H; Liu Z
    J Int Med Res; 2020 Jul; 48(7):300060520937162. PubMed ID: 32692291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.